Weight Loss Isn’t the Same as Fat Loss
Why the composition of lost weight changes the interpretation.
Read the explainer →EVIDENCE, MADE VISUAL
RecompSignal Insights
Short, source-aware explainers that connect scale weight, body composition, clinical evidence and emerging metabolic therapies.
20 visual explainers
6 short videos
Educational research
BODY COMPOSITION
Look beyond the number on the scale.
3 Things the Scale Can’t Tell You
Fat, lean mass, water and glycogen require more context than scale weight.
Explore body composition →
What Body Recomposition Actually Means
Separate changes in fat and lean tissue rather than collapsing them into one number.
Read the guide →
Fat vs Water vs Lean-Mass Loss
Several compartments can move while the scale reports only total weight.
See what the scale misses →MUSCLE PRESERVATION
Track lean tissue and function separately.
Why Muscle Preservation Matters
Strength, function and lean tissue are related—but they are not interchangeable outcomes.
Explore muscle preservation →
What Causes Lean-Mass Loss?
Deficit size, training, protein, measurement and starting composition all matter.
Read the guide →
Why Protein Matters During Fat Loss
Protein is one part of the muscle-preservation evidence picture.
See the evidence context →
Resistance Training Belongs in the Plan
Training provides a distinct muscle-retention signal during energy restriction.
Explore the evidence →THERAPY COMPARISON
Compare mechanisms, evidence and outcomes.
What GLP-1 Evidence Actually Shows
Separate demonstrated outcomes from assumptions and extrapolation.
Compare evidence →
Semaglutide vs Tirzepatide
Mechanisms differ; study context matters when comparing outcomes.
Open the comparison →
Look Beyond the Headline
Population, dose, duration and design shape the percentages.
See the full comparison →
7 Questions to Ask
A structured way to interrogate metabolic-therapy claims.
Use the comparison framework →EVIDENCE LITERACY
Read the study before trusting the headline.
Clinical Evidence Without the Hype
A practical framework for judging how much a claim can support.
See the methodology →
Phase 2 vs Phase 3
Trial phase changes the level of uncertainty, not just the study label.
Compare trial phases →
5 Signs of Stronger Evidence
Replication, controls, endpoints, publication and source quality all matter.
Learn the framework →
How to Read a Weight-Loss Headline
Ask who was studied, for how long, against what comparator and using which estimand.
Read more carefully →PIPELINE
Follow emerging signals without treating them as conclusions.
What’s Next in Metabolic Therapy?
New mechanisms and combinations are moving through clinical development.
Explore the pipeline →
Why the Triple-Agonist Approach Matters
Mechanistic differentiation is scientifically interesting, but outcome evidence remains the test.
Open the Retatrutide Signal Card →
Lean Mass During GLP-1 Therapy
Reported changes depend on study population, therapy and measurement method.
Explore the evidence →
Fast Weight Loss Can Hide What You’re Losing
A large scale change still needs fat, lean-tissue and function context.
See the body-composition lens →